相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
Tomoya Mizuno et al.
BMC CANCER (2015)
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer
James L. Chen et al.
CANCER MEDICINE (2013)
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
Daiki Ueno et al.
BMC CANCER (2012)
Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
Irfan Kayani et al.
CLINICAL CANCER RESEARCH (2011)
Impact of maximum Standardized Uptake Value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report
Kazuhiro Namura et al.
BMC CANCER (2010)
Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma
Jong Wook Park et al.
BJU INTERNATIONAL (2009)
18F-FDG PET/CT Imaging for an Early Assessment of Response to Sunitinib in Metastatic Renal Carcinoma: Preliminary Study
Laetitia Vercellino et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results
Yoo-Young Lee et al.
GYNECOLOGIC ONCOLOGY (2009)
Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomography
David Lyrdal et al.
NUCLEAR MEDICINE COMMUNICATIONS (2009)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
[18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer
R Sasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma
DE Kang et al.
JOURNAL OF UROLOGY (2004)
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection
RJ Downey et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose
AS Allal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases:: a comparison with CT
N Aide et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma
NS Majhail et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
NK Janzen et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
分享论文
